Tone mix
Week by week 52 weeks
Share of EyePoint, Inc. Common Stock's 135 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 10, 2026 · tone -100HC Wainwright Has Bearish Estimate for EYPT Q3 Earnings-131
- Week of Jun 22, 2026 · tone +100Guggenheim Reiterates "Buy" Rating for Eyepoint Pharmaceuticals (NASDAQ:EYPT)+109
- Week of Mar 9, 2026 · tone -100Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Down 4.7% Following Weak Earnings-105
- Week of May 26, 2025 · tone +99EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Exploring a Potential 471% Upside with Innovative Retinal Treatments+100
- Week of Dec 29, 2025 · tone +97The Year-End 2025 Biotech Rally And What It Means For 2026 - Cytokinetics (NASDAQ:CYTK), EyePoint (NASDAQ:EYPT)+92
- Week of Nov 24, 2025 · tone +100Eyepoint Pharmaceuticals (NASDAQ:EYPT) Upgraded by Cantor Fitzgerald to "Strong-Buy" Rating+91
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about EyePoint, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 6 | -44 |
| Last 30 sessions | 18 | -26 |
| Last 90 sessions | 49 | -18 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 26, 2026
1 headline, average tone -84: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.rttnews.com · 1 outletWeekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial WinNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Weekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win | www.rttnews.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletEyepoint Pharmaceuticals' (EYPT) Hold Rating Reiterated at LaidlawNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Eyepoint Pharmaceuticals' (EYPT) Hold Rating Reiterated at Laidlaw | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
2 headlines, average tone -50: 0 positive, 1 neutral and 1 negative. Showing all 2.
- www.dailypolitical.com · 1 outletHC Wainwright Issues Negative Estimate for EYPT EarningsNegative
- www.pr-inside.com · 1 outletEYPT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation ...Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| HC Wainwright Issues Negative Estimate for EYPT Earnings | www.dailypolitical.com | 1 | Negative |
| EYPT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation ... | www.pr-inside.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
2 headlines, average tone -40: 0 positive, 1 neutral and 1 negative. Showing all 2.
- www.prnewswire.com · 1 outletEYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint PharmaceuticalsNegative
- www.themarketsdaily.com · 1 outletEyepoint Pharmaceuticals' (EYPT) "Hold" Rating Reiterated at LaidlawNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals | www.prnewswire.com | 1 | Negative |
| Eyepoint Pharmaceuticals' (EYPT) "Hold" Rating Reiterated at Laidlaw | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
5 headlines, average tone -41: 1 positive, 1 neutral and 3 negative. Showing all 5.
- www.rttnews.com · 1 outletEyePoint's DURAVYU Misses Primary Goal Despite Reduced Treatment Burden; Stock DownNegative
- www.tickerreport.com · 1 outletEyepoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by Jefferies Financial Group to "Hold"Negative
- www.rttnews.com · 1 outletEyePoint's DURAVYU Misses Primary Endpoint In Phase 3 Wet AMD TrialNegative
- www.dailypolitical.com · 1 outletEyepoint Pharmaceuticals' (EYPT) "Neutral" Rating Reaffirmed at MizuhoPositive
- www.rttnews.com · 1 outletEyePoint Announces Strategic Prioritization To Reduce Operating Expenses; To Cut WorkforceNeutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| EyePoint's DURAVYU Misses Primary Goal Despite Reduced Treatment Burden; Stock Down | www.rttnews.com | 1 | Negative |
| Eyepoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by Jefferies Financial Group to "Hold" | www.tickerreport.com | 1 | Negative |
| EyePoint's DURAVYU Misses Primary Endpoint In Phase 3 Wet AMD Trial | www.rttnews.com | 1 | Negative |
| Eyepoint Pharmaceuticals' (EYPT) "Neutral" Rating Reaffirmed at Mizuho | www.dailypolitical.com | 1 | Positive |
| EyePoint Announces Strategic Prioritization To Reduce Operating Expenses; To Cut Workforce | www.rttnews.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about EyePoint, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.